An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.
Clinical trial NCT00420056 · COMPLETED
Trial details
- NCT number
- NCT00420056
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2010-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.